期刊文献+

白念珠菌菌丝相与酵母相ERG11基因部分序列比较研究

Comparative study on the partial ERG11 gene sequence between the yeast and hyphal forms of Candida albicans
下载PDF
导出
摘要 目的通过对白念珠菌菌丝相与酵母相ERG11基因部分序列的比较,探讨两相细胞在DNA水平的差异。方法分别抽提7株来自同一亲本且对氟康唑敏感性不同的白念珠菌菌丝相与酵母相基因组DNA,根据ERG11基因编码序列设计一对引物,对ERG11基因第948位点至第1 254位点307bp的碱基序列进行PCR扩增,以PCR产物直接测序比较两相在该片段碱基序列上的差异。结果7株白念珠菌菌丝相与酵母相在该片段的碱基序列无差异。结论白念珠菌菌丝相与酵母相ERG11基因的第948位点至第1 254位点序列无差异。 The differences on DNA sequences between yeast and hyphal forms of Candida albicans were compared by a study on the partial ERG11 gene sequence, in which the genome DNA from yeast and hyphal forms of 7 strains of C. albicans (CA-9, CA- 11, CA-13, CA-14, CA-15, CA-16 and CA-17)isolated from HIV-seropositive patients with different sensitivity to fluconazole was extracted and amplified by PCR with a pair of primers designated according to the ERG11 gene coding sequence. The position 948 to 1 254 of the ERG11 gene from the yeast and hyphal forms of these 7 strains of C. albicans could be amplified by PCR technique and then sequenced directly, but there was no sequence difference between the yeast and hyphal forms of these 7 strains of C. akbicans at position 948 to 1254 of the ERG11 gene.
出处 《中国人兽共患病杂志》 CAS CSCD 北大核心 2005年第10期845-846,854,共3页 Chinese Journal of Zoonoses
基金 广东省科技计划项目(No2004B33101004)
关键词 白念珠菌 菌丝相 酵母相 ERG11基因 差异 Candida albicans hyphal form yeast form difference ERG 11
  • 相关文献

参考文献10

二级参考文献17

  • 1王鲁,叶庆佾,唐书谦.白念珠菌芽管特异性抗原的研究[J].中华皮肤科杂志,1994,27(3):136-138. 被引量:12
  • 2White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, 1998, 11: 382-402.
  • 3White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14 alpha demethylase in Candida albicans. Antimicrob Agents Chemother, 1997, 41: 1488-1494.
  • 4Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis, 1994, 18: 240-242.
  • 5White TC, Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient. Oral Dis, 1997, 3 Suppl 1: S102-109.
  • 6Ponton J, Jones JM. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun, 1986, 53: 565-572.
  • 7Liu H. Transcriptional control of dimorphism in Candida albicans.Curr Opin Microbiol, 2001, 4: 728-735. [9]Schaude M, Ackerbauer H, Mieth H. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans. Mykosen, 1987,30: 281-287.
  • 8Schaude M,Ackerbauer H,lnhibitory effect of antifungal agents on germ tube formation in Candida albicans.Mykosen, 1987,30:281-287.
  • 9郭宁如,现代真菌病诊断治疗学,1997年,51页
  • 10Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS:documentation by in vitro susceptibility testing and DNA subtype analysis[J]. Clin Infect Dis, 1994,

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部